4/11/2020 https://emedicine.medscape.

com/article/305937-print

emedicine.medscape.com

Cervical Myofascial Pain

Updated: Jan 13, 2020
Author: Grant Cooper, MD; Chief Editor: Dean H Hommer, MD

Overview

Practice Essentials
Pain attributed to muscle and its surrounding fascia is termed myofascial pain, with cervical myofascial pain thought to occur
following either overuse of or trauma to the muscles that support the shoulders and neck. It can also result from
compensation for an underlying spinal problem such as facet joint arthropathy or an annular tear in one of the discs. In the
cervical spine, the muscles most often implicated in myofascial pain are the trapezius, levator scapulae, rhomboids,
supraspinatus, and infraspinatus.[1, 2] (See Etiology.) Treatments for cervical myofascial pain include physical therapy, trigger
point injection, stretch-and-spray therapy, and ischemic compression.[3]

Myofascial pain in any location is characterized on examination by the presence of trigger points located in skeletal muscle. A
trigger point is defined as a hyperirritable area located in a palpable, taut band of muscle fibers (see the image below). (See
Etiology, Presentation, and Treatment.)

Schematic of a trigger point complex of a muscle in longitudinal section. A: The central trigger point (CTrP) in the endplate
zone contains numerous electrically active loci and numerous contraction knots. A taut band of muscle fibers extends from
the trigger point to the attachment at each end of the involved fibers. The sustained tension that the taut band exerts on the
attachment tissues can induce a localized enthesopathy that is identified as an attachment trigger point (ATrP). B: Enlarged
view of part of the CTrP shows the distribution of 5 contraction knots. The vertical lines in each muscle fiber identify the
relative spacing of its striations. The space between 2 striations corresponds to the length of 1 sarcomere. The sarcomeres
within one of these enlarged segments (ie, contraction knot) of a muscle fiber are markedly shorter and wider than the
sarcomeres in the neighboring normal muscle fibers, which are free of contraction knots.
https://emedicine.medscape.com/article/305937-print 1/16
4/11/2020 https://emedicine.medscape.com/article/305937-print
Descriptions of myofascial pain date back to the mid-19th century, when Froriep described muskelschwiele, or muscle calluses.
He characterized these calluses as tender areas in muscle that felt like a cord or band associated with rheumatic complaints. In
the early 1900s, Gowers first used the term fibrositis to describe muscular rheumatism associated with local tenderness and
regions of palpable hardness.

In 1938, Kellgren described areas of referred pain associated with tender points in muscle. In the 1940s, Janet Travell, MD,
began writing about myofascial trigger points. Her text, written in conjunction with David Simons, MD, continues to be viewed as
the foundational literature on the subject of myofascial pain.[4]

The primary concern for patients with cervical myofascial pain is chronicity. Recurrence of myofascial pain is a common
scenario. Prompt treatment prevents other muscles in the functional unit from compensating and, consequently, producing a
more widespread and chronic problem. Migraine headaches and muscle contraction headaches are known to occur frequently
in the patient with myofascial pain.[5] Temporomandibular joint (TMJ) syndrome also may be myofascial in origin. (See
Prognosis, Presentation, Treatment, and Medication.)[1]

Symptoms of cervical myofascial pain

These include the following:

Cervical spine range of motion (ROM) is often limited and painful

The patient may describe a lumpiness or painful bump in the trapezius or cervical paraspinal muscles
Massage is often helpful, as is superficial heat
The patient's sleep may be interrupted because of pain
The cervical rotation required for driving is difficult to achieve
The patient may describe pain radiating into the upper extremities, accompanied by numbness and tingling, making
discrimination from radiculopathy or peripheral nerve impingement difficult
Dizziness or nausea may be a part of the symptomatology
The patient experiences typical patterns of radiating pain referred from trigger points

Workup in cervical myofascial pain

The diagnosis of myofascial pain is clinical, with no confirmatory laboratory tests available. Magnetic resonance imaging (MRI)
may be helpful in ruling out any significant abnormality within the structure of the cervical vertebrae or spinal canal. The cervical
discs also may be evaluated. If the pain is in the shoulders or chest wall, be aware that visceral pain may refer to these areas
and even produce some myofascial findings on examination. Be open-minded to the possibility that another problem also may
be present.

It may also be reasonable, depending on the clinical presentation, to check for indicators of inflammation, assess thyroid
function, and perform a basic metabolic panel to rule out a concomitant medical illness.

Management of cervical myofascial pain

The primary goal of physical therapy is to restore balance between muscles working as a functional unit. The physical therapist
may progress toward that goal initially by attempting to diminish pain. This goal can be accomplished using a modality-based
approach performed in conjunction with myofascial release techniques and massage. Cervical stretch and stabilization are
integral parts of the approach as well. Postural retraining is crucial in cervical myofascial pain. An ergonomic evaluation may be
indicated if overuse in the work setting is contributing to the patient's symptoms.

Trigger point injection probably is one of the most accepted means of treating myofascial pain besides physical therapy and
exercise. Injection is performed most commonly with local anesthetic, although dry needling has been shown to be equally
effective.[6]

Stretch and spray is another method of treating cervical myofascial pain. This technique is performed using a vapocoolant spray
applied to the affected muscle after it has been placed in passive stretch.

Ischemic compression involves application of sustained pressure on the trigger point. Have the patient place the muscle in a
fully stretched position. Press firmly on the trigger point with a thumb. Gradually increase the pressure as the pain lessens.

Botulinum toxin (BoNT) injection therapy has received mixed reviews in the literature. Injection directly into the trigger point
produces inconsistent results. The best use of BoNT may be for correcting abnormal biomechanics that incite a myofascial
response.[7, 8]

https://emedicine.medscape.com/article/305937-print 2/16
4/11/2020 https://emedicine.medscape.com/article/305937-print

Etiology
Cervical myofascial pain is thought to occur following either overuse of or trauma to the muscles that support the shoulders and
neck. It can also occur as a reaction to an underlying spinal pathology such as facet joint arthropathy or an annular tear in one
of the cervical discs. Common scenarios among patients are recent involvement in a motor vehicle accident or performance of
repetitive upper extremity activities.

In the cervical spine, the muscles most often implicated in myofascial pain are the trapezius, levator scapulae, rhomboids,
supraspinatus, and infraspinatus.[1] Trapezial myofascial pain commonly occurs when a person with a desk job does not have
appropriate armrests or must type on a keyboard that is too high.

Other issues that may play a role in the clinical picture of cervical myofascial pain include endocrine dysfunction, chronic
infections, nutritional deficiencies, poor posture, and psychological stress.

Epidemiology
Occurrence in the United States

Myofascial pain is thought to occur commonly in the general population. As many as 21% of patients seen in general orthopedic
clinics have myofascial pain. Of patients seen at specialty pain management centers, 85-93% have a myofascial pain
component to their condition.

International occurrence

A South American study, by Munoz-Ceron et al, reported that of emergency department patients with nontraumatic headaches,
cervical myofascial pain was the most frequent nonprimary cause.[9]

Sex- and age-related demographics

Cervical myofascial pain occurs in both sexes, but with a predominance among women. Myofascial pain seems to occur more
frequently with increasing age until midlife. The incidence declines gradually after middle age.

Prognosis
When the patient with cervical myofascial pain undergoes appropriate treatment (eg, physical therapy, massage therapy, stretch
and spray, trigger point injections, identification and elimination of an underlying, triggering pathology), the prognosis is generally
good. However, recurrence can be a common scenario. Outcomes seem to be better when treatment is initiated early in order to
prevent compensation patterns that exacerbate pain. Increased mortality is not associated with cervical myofascial pain.

A Turkish study found evidence that patient disability in chronic myofascial pain is most strongly linked to the duration of pain.
The report's assessment was based on data collected from 103 female patients with the chronic disorder and from 30 healthy
female participants, using the Neck Pain and Disability Scale, the Beck Depression Inventory, and a visual analog scale, as well
as pain pressure threshold measurements from common cervical myofascial pain trigger points.[1]

Patient Education
Patients with cervical myofascial pain need to be educated regarding the factors or underlying problems that may contribute to
their pain and loss of mobility. The physical therapist can educate the patient on proper exercise habits and instruct them in a
home exercise program for stretching and reconditioning. The patient also may benefit from specific exercises and strategies to
improve posture awareness and body mechanics with activities of daily living. If poor workplace ergonomics contribute to the

https://emedicine.medscape.com/article/305937-print 3/16
4/11/2020 https://emedicine.medscape.com/article/305937-print
patient's condition, offer instruction in proper ways to modify and revamp the workstation. Cervical myofascial pain is a treatable
condition if the patient is educated on the condition and takes an active role in the recovery process.

For patient education information, see Temporomandibular Joint (TMJ) Syndrome, Fibromyalgia, and Chronic Pain.

Presentation

History
The diagnosis of myofascial pain is clinical, with no confirmatory laboratory tests available. The patient with cervical myofascial
pain may present with a history of acute trauma associated with persistent muscular pain. However, myofascial pain can also
manifest insidiously, without a clear antecedent accident or injury. It may be associated with repetitive tasks, poor posture,
stress, or cold weather. Typical findings reported by patients also include the following:

Cervical spine range of motion (ROM) is often limited and painful

The patient may describe a lumpiness or painful bump in the trapezius or cervical paraspinal muscles

Massage is often helpful, as is superficial heat

The patient's sleep may be interrupted because of pain

The cervical rotation required for driving is difficult to achieve

The patient may describe pain radiating into the upper extremities, accompanied by numbness and tingling, making
discrimination from radiculopathy or peripheral nerve impingement difficult

Dizziness or nausea may be a part of the symptomatology

The patient experiences typical patterns of radiating pain referred from trigger points

Physical Examination
Common findings noted upon physical examination include the following:

Patients with cervical myofascial pain often present with poor posture; they exhibit rounded shoulders and protracted
scapulae

Trigger points frequently are noted in the trapezius, supraspinatus, infraspinatus, rhomboids, and levator scapulae
muscles

The palpable, taut band is noted in the skeletal muscle or surrounding fascia; a local twitch response often can be
reproduced with palpation of the area

ROM of the cervical spine is limited, with pain reproduced in positions that stretch the affected muscle

While the patient may complain of weakness, normal strength in the upper extremities is noted on physical examination

Sensation typically is normal when tested formally; no long tract signs are observed on examination

Myofascial pain in any location is characterized on examination by the presence of trigger points located in skeletal muscle. A
trigger point is defined as a hyperirritable area located in a palpable, taut band of muscle fibers. According to Hong and Simon's
review on the pathophysiology and electrophysiologic mechanisms of trigger points, the following observations help to define
them further[10] :

Trigger points are known to elicit local pain and/or referred pain in a specific, recognizable distribution

https://emedicine.medscape.com/article/305937-print 4/16
4/11/2020 https://emedicine.medscape.com/article/305937-print
Palpation in a rapid fashion (ie, snapping palpation) may elicit a local twitch response, a brisk contraction of the muscle
fibers in or around the taut band; the local twitch response also can be elicited by rapid insertion of a needle into the
trigger point (see the images below)

Restricted ROM and increased sensitivity to stretch of muscle fibers in a taut band are noted frequently

The muscle with a trigger point may be weak because of pain; usually, no atrophic change is observed

Patients with trigger points may have associated localized autonomic phenomena (eg, vasoconstriction, pilomotor
response, ptosis, hypersecretion)

An active myofascial trigger point is a site marked by generation of spontaneous pain or pain in response to movement;
in contrast, latent trigger points may not produce pain until they are compressed

Cross-sectional drawing shows flat palpation of a taut band and its trigger point. Left: A. The skin is pushed to one side
to begin palpation. B. The fingertip slides across muscle fibers to feel the cord-line texture of the taut band rolling
beneath it. C. The skin is pushed to the other side at completion of the movement. This same movement performed
vigorously is called snapping palpation. Right: A. Muscle fibers are surrounded by the thumb and fingers in a pincer
grip. B. The hardness of the taut band is felt clearly as it is rolled between the digits. C. The palpable edge of the taut
band is sharply defined as it escapes from between the fingertips, often with a local twitch response.

https://emedicine.medscape.com/article/305937-print 5/16
4/11/2020 https://emedicine.medscape.com/article/305937-print

Longitudinal schematic drawing of taut bands, myofascial trigger points, and a local twitch response. A: Palpation of a
taut band (straight lines) among normally slack, relaxed muscle fibers (wavy lines). B: Rolling the band quickly under
the fingertip (snapping palpation) at the trigger point often produces a local twitch response, which usually is seen most
clearly as skin movement between the trigger point and the attachment of the muscle fibers.

DDx

Differential Diagnoses
Cervical Disc Disease

Cervical Spondylosis

Cervical Sprain and Strain

Rehabilitation and Fibromyalgia

Rheumatoid Arthritis (RA)

Thoracic Outlet Syndrome

Workup

Workup

Approach Considerations
As previously stated, the diagnosis of myofascial pain is clinical, with no confirmatory laboratory tests available. In addition,
imaging studies often reveal nonspecific change only and typically are not helpful in making the diagnosis of cervical myofascial
pain.

https://emedicine.medscape.com/article/305937-print 6/16
4/11/2020 https://emedicine.medscape.com/article/305937-print

However, cervical myofascial pain can be present at the same time as other, more serious medical conditions. If the patient's
symptoms are resistant to traditional treatment for cervical myofascial pain, further workup is indicated. If a history of trauma
exists, order cervical flexion/extension films to rule out the possibility of instability.

Magnetic resonance imaging (MRI) may be helpful in ruling out any significant abnormality within the structure of the cervical
vertebrae or spinal canal. The cervical discs also may be evaluated. If the pain is in the shoulders or chest wall, be aware that
visceral pain may refer to these areas and even produce some myofascial findings on examination. Be open-minded to the
possibility that another problem also may be present.

It may also be reasonable, depending on the clinical presentation, to check for indicators of inflammation, assess thyroid
function, and perform a basic metabolic panel to rule out a concomitant medical illness.

Travell and Simons described a study looking at lactate dehydrogenase (LDH) isoenzymes in which a shift was noted in the
distribution of the isoenzymes, with higher levels of LDH1 and LDH2, while the total LDH remained within normal limits.[4]

Electrophysiologic Studies
Several research articles have attempted to identify changes on electromyograms/nerve conduction velocity studies that may be
unique to patients with myofascial pain. The research has been somewhat contradictory, with some studies finding no real
electromyographic activity and others finding nonspecific electrical activity.

Studies by Simons and by Hobbard and Berkoff described low-amplitude action potentials recorded at the region of the
myofascial trigger point. Spontaneous electrical activity apparently can be detected using high-sensitivity recordings at the site
of the trigger point. The spontaneous electrical activity may be a type of endplate potential.

A study by Ballyns et al describes the use of sonoelastography in classifying myofascial trigger points by active, latent, and
normal sites. Although not yet clinically useful, employing sonoelastography to assess the trigger point areas and pulsatility
index may help to determine myofascial pain syndrome's natural history.[11]

Treatment

Approach Considerations
Treatments for cervical myofascial pain include physical therapy, trigger point injection, stretch-and-spray therapy, and ischemic
compression. Injection of botulinum toxin (BoNT) has also been used, although this procedure has received mixed reviews in
the literature.

Various pain-relieving medications can also be employed in treatment, including the following:

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Tricyclic antidepressants

Muscle relaxants[12]

Nonnarcotic analgesics

Anticonvulsants

A study by Park et al indicated that extracorporeal shock-wave therapy (ESWT) can effectively treat myofascial pain syndrome
of the upper trapezius, producing improvement in verbal numeric pain scale and Neck Disability Index scores, as well as in
pressure threshold and neck range of motion (ROM). The investigators also reported that posttreatment improvements in the
Neck Disability Index and in neck flexion were significantly greater in patients who received high-energy ESWT than in those
who underwent low-energy therapy.[13]

https://emedicine.medscape.com/article/305937-print 7/16
4/11/2020 https://emedicine.medscape.com/article/305937-print

Physical Therapy
The primary goal of physical therapy is to restore balance between muscles working as a functional unit. The physical therapist
may progress toward that goal initially by attempting to diminish pain. This goal can be accomplished using a modality-based
approach performed in conjunction with myofascial release techniques and massage. Cervical stretch and stabilization are
integral parts of the approach as well. Postural retraining is crucial in cervical myofascial pain. An ergonomic evaluation may be
indicated if overuse in the work setting is contributing to the patient's symptoms.

In a study by Sherman et al, the authors concluded that massage may provide short-term relief for chronic neck pain. In this
randomized, controlled trial, the investigators evaluated whether therapeutic massage is more beneficial than a self-care book
for patients with chronic neck pain. Patients (n=64) were randomized to receive up to 10 massages over 10 weeks or a self-care
book. Measurement of the Neck Disability Index at 10 weeks demonstrated more participants randomized to massage
experienced clinically significant improvement (39%) than did the participants in the self-care book group (14%). However, a
larger trial is warranted to confirm these results.[14]

In a study by Ma et al, patients who underwent biofeedback training to the bilateral upper trapezius showed greater reduction in
work-related pain and better neck muscle activation than did patients who underwent exercise therapy or passive treatment
modalities.[15]

A study by Bronfort et al concluded that both spinal manipulation treatment and a home exercise program were both superior to
medication alone in the treatment of acute and subacute neck pain. No significant differences were seen in the outcome when
comparing 12 weeks of manipulation to a home exercise program taught by a therapist in 2 separate sessions.[16]

A randomized, double-blind, placebo-controlled study by Ay et al indicated that kinesiology taping improves pain, the pressure
pain threshold, and cervical ROM in patients with cervical myofascial pain syndrome but does not improve disability in the short-
term. The study included 31 patients who underwent kinesiology taping and 30 patients who underwent sham taping.[17]

A study by Moustafa et al indicated that in patients with chronic cervical myofascial pain syndrome and defined abnormalities in
cervical sagittal posture, the use of a Denneroll cervical orthotic device in combination with integrated neuromuscular inhibition
technique (INIT) leads, possibly through improvement of sagittal cervical posture alignment, to better results with regard to
pressure pain thresholds and cervical range of motion than does INIT alone.[18]

A prospective, randomized clinical study by Aydin et al indicated that exercise therapy can effectively treat dizziness associated
with cervical myofascial pain syndrome, with a combination of exercise and dry needling producing better results than exercise
alone. The severity of dizziness, weekly number of dizziness attacks, fall index, and Dizziness Handicap Inventory were among
the measurements used in deriving the results.[19]

Trigger Point Injection

Several treatment options for cervical myofascial pain are discussed in the literature. Trigger point injection probably is one of
the most accepted means of treating myofascial pain besides physical therapy and exercise. Injection is performed most
commonly with local anesthetic, although dry needling has been shown to be equally effective.[6]

Palpate the trigger point in the taut band, and place the muscle in a slightly stretched position to prevent it from moving. Hold the
trigger point between 2 fingers while injecting with the other hand, and then redirect the needle in the area to assure widespread
infiltration of the anesthetic. (See the image below.)

https://emedicine.medscape.com/article/305937-print 8/16
4/11/2020 https://emedicine.medscape.com/article/305937-print

Cross-sectional schematic drawing shows flat palpation to localize and hold the trigger point for injection. A and B show the
use of alternate pressure between 2 fingers to confirm the location of the palpable module of the trigger point. C shows the
trigger point being positioned halfway between the fingertips to keep it from sliding to one side during the injection.

Instruct the patient to be aggressive about compliance with stretching protocols, because they increase the injection's
effectiveness. Production of a local twitch response helps to confirm the diagnosis. Hong and Simon's article describes a fast-
in/fast-out method as more successful in eliciting the local twitch response.[10] This approach, therefore, generally is the most
helpful technique for reducing myofascial pain.

A retrospective study by Affaitati et al indicated that in patients in whom target areas of myofascial cervical trigger points
coincide with migraine pain sites, topical treatment of the trigger points with 3% nimesulide gel is as effective against migraine
headache as injection of the trigger points with local anesthetic.[20]

Stretch and Spray, Ischemic Compression, and Botulinum Toxin

Stretch and spray

Stretch and spray is another method of treating cervical myofascial pain (see the images below). This technique is performed
using a vapocoolant spray applied to the affected muscle after it has been placed in passive stretch. Apply the vapocoolant
spray to the region around the trigger point and the area of referred pain using parallel strokes in the same direction. Some
authors recommend first spraying, then stretching, and only then repeating the spraying.

https://emedicine.medscape.com/article/305937-print 9/16
4/11/2020 https://emedicine.medscape.com/article/305937-print

Sequence of steps to use when stretching and spraying any muscle for myofascial trigger points.

Schematic drawing showing how the jet stream of vapocoolant is applied.

Ischemic compression

Ischemic compression involves application of sustained pressure on the trigger point. Have the patient place the muscle in a
fully stretched position. Press firmly on the trigger point with a thumb. Gradually increase the pressure as the pain lessens.

Botulinum toxin

BoNT injection therapy has received mixed reviews in the literature. Injection directly into the trigger point produces inconsistent
results. The best use of BoNT may be for correcting abnormal biomechanics that incite a myofascial response.[7, 8]

A study by Nicol et al of patients with cervical myofascial pain found improvements in pain when BoNT-A was injected directly
into painful muscle groups. The study began with 114 patients with cervical and shoulder girdle myofascial pain who were
injected with BoNT-A and assessed for their response to it. The investigators then conducted a 12-week, randomized, double-
blind, placebo-controlled trial with 54 responders, who received either a second injection of BoNT-A, administered directly into a
painful muscle group, or a placebo. Improvements in pain, as measured with visual numerical pain scores and Brief Pain
Inventory general activity and sleep interference scores, were seen in the BoNT-A group, in comparison with the placebo group.
Patients in the BoNT-A group also experienced a decrease in the weekly number of headaches.[21]

https://emedicine.medscape.com/article/305937-print 10/16
4/11/2020 https://emedicine.medscape.com/article/305937-print

Medication

Medication Summary
The goal of medication for patients with cervical myofascial syndrome is to reduce pain. Avoid the use of opioid analgesics. If
the clinical picture is one of more chronic pain accompanied by sleep dysfunction, consider the use of a tricyclic antidepressant
(TCA). Anticonvulsants used as neuropathic analgesics may be helpful, because myofascial pain may at its core be a spinal-
mediated disorder affected by neuropathic dysfunction. Muscle relaxants, although commonly administered to treat muscle pain,
must be used cautiously because of their sedative effects and, in some cases, addictive potential.[12]

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Class Summary
NSAIDs are the drugs of choice for the initial treatment of myofascial pain.

Ibuprofen (Motrin, Advil, Neoprofen, Ultraprin)

Ibuprofen inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis. It is used to provide relief of cervical
myofascial pain.

Indomethacin (Indocin)
Indomethacin is thought to be the most effective NSAID for the treatment of ankylosing spondylitis, although no scientific
evidence supports this claim. It is used for relief of mild to moderate pain; it inhibits inflammatory reactions and pain by
decreasing the activity of COX, which results in a decrease of prostaglandin synthesis.

Naproxen (Naprosyn, Naprelan, Aleve, Anaprox)

Naproxen is used for relief of mild to moderate pain; it inhibits inflammatory reactions and pain by decreasing the activity of
COX, which results in a decrease of prostaglandin synthesis.

Diclofenac (Voltaren, Cataflam XR, Zipsor, Cambia)

Diclofenac inhibits prostaglandin synthesis by decreasing COX activity, which, in turn, decreases formation of prostaglandin
precursors.

Ketoprofen
Ketoprofen is used for relief of mild to moderate pain and inflammation. Small dosages are indicated initially in small patients,
elderly patients, and patients with renal or liver disease. Doses higher than 75 mg do not increase the therapeutic effects.
Administer high doses with caution, and closely observe the patient's response.

Tricyclic Antidepressants

Class Summary

https://emedicine.medscape.com/article/305937-print 11/16
4/11/2020 https://emedicine.medscape.com/article/305937-print
Tricyclic antidepressants are commonly used for chronic pain. They help to treat insomnia and reduce painful dysesthesia.
These agents treat nociceptive and neuropathic pain syndromes.

Amitriptyline
Amitriptyline inhibits the reuptake of serotonin and/or norepinephrine at the presynaptic neuronal membrane, which increases
their concentration in the central nervous system (CNS). Amitriptyline may increase or prolong neuronal activity, since the
reuptake of these biogenic amines is important physiologically in terminating transmitting activity.

Skeletal Muscle Relaxants

Class Summary
Muscle relaxants are commonly used to treat muscle pain, but they must be used cautiously because of sedation and because
of the addictive potential of some of the medications in this category of drugs (benzodiazepines).

Cyclobenzaprine (Flexeril, Fexmid, Amrix)

Cyclobenzaprine acts centrally and reduces motor activity of tonic somatic origins, influencing alpha and gamma motor neurons.
It is structurally related to the tricyclic antidepressants.

Skeletal muscle relaxants have modest, short-term benefit as adjunctive therapy for nociceptive pain associated with muscle
strains and, used intermittently, for diffuse and certain regional chronic pain syndromes. Long-term improvement over placebo
has not been established.

Cyclobenzaprine often produces a "hangover" effect, which can be minimized by taking the nighttime dose 2-3 hours before
going to sleep.

Baclofen (Lioresal, Gablofen)

Baclofen is metabolized in the liver and excreted primarily in urine. This agent is not a controlled substance under the Drug
Enforcement Administration (DEA).

Carisoprodol (Soma)
Carisoprodol is a short-acting medication that may have depressant effects at the spinal cord level.

Skeletal muscle relaxants have modest short-term benefit as adjunctive therapy for nociceptive pain associated with muscle
strains and, used intermittently, for diffuse and certain regional chronic pain syndromes. Long-term improvement over placebo
has not been established.

Tizanidine (Zanaflex)
Tizanidine is a centrally acting muscle relaxant that is metabolized in the liver and excreted in the urine and feces. It is used in
patients with predominantly upper motor neuron involvement. It is not a DEA-controlled substance.

Opioid Analgesics

Class Summary

https://emedicine.medscape.com/article/305937-print 12/16
4/11/2020 https://emedicine.medscape.com/article/305937-print
Tramadol is a weak opioid and an inhibitor of serotonin and norepinephrine reuptake in the dorsal horn. Studies have shown
efficacy when it has been used to treat fibromyalgia, although no formal studies have been performed for myofascial pain.
Tramadol is known to help with chronic low back pain and osteoarthritic pain, both of which are commonly associated with
myofascial pain.

Tramadol (Ultram, Ryzolt)

Tramadol is an analgesic that probably acts over monoaminergic and opioid mechanisms. Its monoaminergic effect is shared
with tricyclic antidepressants. Tolerance and dependence appear to be uncommon.

Anticonvulsants, Other

Class Summary
Anticonvulsants used as neuropathic analgesics may be helpful, because myofascial pain may at its core be a spinal-mediated
disorder affected by neuropathic dysfunction. Gabapentin has been shown to be effective in treating myofascial and neuropathic
pain.

Gabapentin (Neurontin)
Gabapentin is a membrane stabilizer. It is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid
(GABA), but, paradoxically, it is thought not to exert an effect on GABA receptors. Gabapentin appears to exert action via the
alpha(2)delta1 and alpha(2)delta2 auxiliary subunits of voltage-gaited calcium channels. It is used to manage pain and provide
sedation in neuropathic pain.

Titration to effect occurs over several days (300 mg on day 1, 300 mg twice on day 2, and 300 mg 3 times on day 3).

Questions & Answers

Overview

What is cervical myofascial pain?

What causes cervical myofascial pain?

What is the prevalence of cervical myofascial pain in the US and internationally?

Which patient groups have the highest prevalence of cervical myofascial pain?

What is the prognosis of cervical myofascial pain?

What is included in patient education about cervical myofascial pain?

Presentation

Which clinical history findings are characteristic of cervical myofascial pain?

Which physical findings are characteristic of cervical myofascial pain?

What are the characteristics of trigger points in cervical myofascial pain?

DDX

What are the differential diagnoses for Cervical Myofascial Pain?

Workup

https://emedicine.medscape.com/article/305937-print 13/16
4/11/2020 https://emedicine.medscape.com/article/305937-print
How is cervical myofascial pain diagnosed?

What is the role of imaging studies in the workup of cervical myofascial pain?

What is the role of lab tests in the workup of cervical myofascial pain?

What is the role of electrophysiologic studies in the workup of cervical myofascial pain?

Treatment

How is cervical myofascial pain treated?

What is the role of extracorporeal shock-wave therapy (ESWT) in the treatment of cervical myofascial pain?

What is the role of physical therapy in the treatment of cervical myofascial pain?

What is the role of trigger point injection in the treatment of cervical myofascial pain?

What is the role of stretch and spray in the treatment of cervical myofascial pain?

What is the role of ischemic compression in the treatment of cervical myofascial pain?

What is the role of botulinum toxin (BoNT) in the treatment of cervical myofascial pain?

Medications

What is the role of medications in the treatment of cervical myofascial pain?

Which medications in the drug class Anticonvulsants, Other are used in the treatment of Cervical Myofascial Pain?

Which medications in the drug class Opioid Analgesics are used in the treatment of Cervical Myofascial Pain?

Which medications in the drug class Skeletal Muscle Relaxants are used in the treatment of Cervical Myofascial Pain?

Which medications in the drug class Tricyclic Antidepressants are used in the treatment of Cervical Myofascial Pain?

Which medications in the drug class Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are used in the treatment of Cervical
Myofascial Pain?

Contributor Information and Disclosures

Author

Grant Cooper, MD Co-Founder, Co-Director, Princeton Spine and Joint Center

Grant Cooper, MD is a member of the following medical societies: Sigma Xi

Disclosure: Nothing to disclose.

Chief Editor

Dean H Hommer, MD Chief Medical Officer, William Beaumont Army Medical Center

Dean H Hommer, MD is a member of the following medical societies: American Academy of Pain Medicine, American Academy
of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American
College of Healthcare Executives, American Association for Physician Leadership, American Society of Regional Anesthesia
and Pain Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Beth B Froese, MD Consulting Staff, Department of Physical Medicine and Rehabilitation, Orthopaedic Associates of DuPage,
Ltd

Beth B Froese, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation,
https://emedicine.medscape.com/article/305937-print 14/16
4/11/2020 https://emedicine.medscape.com/article/305937-print
American Medical Association, Illinois State Medical Society

Disclosure: Nothing to disclose.

C Douglas Phillips, MD, FACR Director of Head and Neck Imaging, Division of Neuroradiology, New York-Presbyterian
Hospital; Professor of Radiology, Weill Cornell Medical College

C Douglas Phillips, MD, FACR is a member of the following medical societies: American College of Radiology, American
Medical Association, American Society of Head and Neck Radiology, American Society of Neuroradiology, Association of
University Radiologists, Radiological Society of North America

Disclosure: Nothing to disclose.

Acknowledgements

Martin K Childers, DO, PhD Professor, Department of Neurology, Wake Forest University School of Medicine; Professor,
Rehabilitation Program, Institute for Regenerative Medicine, Wake Forest Baptist Medical Center

Martin K Childers, DO, PhD is a member of the following medical societies: American Academy of Physical Medicine and
Rehabilitation, American Congress of Rehabilitation Medicine, American Osteopathic Association, Christian Medical & Dental
Society, and Federation of American Societies for Experimental Biology

Disclosure: Allergan pharma Consulting fee Consulting

Patrick M Foye, MD Associate Professor of Physical Medicine and Rehabilitation, Co-Director of Musculoskeletal Fellowship,
Co-Director of Back Pain Clinic, Director of Coccyx Pain Service (Tailbone Pain Service: www.TailboneDoctor.com), University of
Medicine and Dentistry of New Jersey, New Jersey Medical School

Patrick M Foye, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation,
American Association of Neuromuscular and Electrodiagnostic Medicine, Association of Academic Physiatrists, and
International Spine Intervention Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy;
Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References

1. Duyur Cakit B, Genc H, Altuntas V, et al. Disability and related factors in patients with chronic cervical myofascial pain. Clin
Rheumatol. 2009 Feb 18. [Medline].

2. Touma J, Isaacson AC. Pain, Cervical Myofascial. 2018 Jan. [Medline]. [Full Text].

3. Touma J, May T, Isaacson AC. Cervical Myofascial Pain. StatPearls. 2019 Jan. [Medline]. [Full Text].

4. Travell JG, Simons DG. Myofascial Pain and Dysfunction. Baltimore, Md: Lippincott Williams & Wilkins; 1992. vol 2:

5. Harden RN, Cottrill J, Gagnon CM, et al. Botulinum toxin A in the treatment of chronic tension-type headache With cervical
myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study. Headache. 2008 Oct 10. [Medline].

6. Lee SH, Chen CC, Lee CS, et al. Effects of needle electrical intramuscular stimulation on shoulder and cervical myofascial pain
syndrome and microcirculation. J Chin Med Assoc. 2008 Apr. 71(4):200-6. [Medline].

7. Jabbari B. Botulinum neurotoxins in the treatment of refractory pain. Nat Clin Pract Neurol. 2008 Dec. 4(12):676-85. [Medline].

8. Jeynes LC, Gauci CA. Evidence for the use of botulinum toxin in the chronic pain setting--a review of the literature. Pain Pract. 2008
Jul-Aug. 8(4):269-76. [Medline].

9. Munoz-Ceron J, Marin-Careaga V, Pena L, Mutis J, Ortiz G. Headache at the emergency room: etiologies, diagnostic usefulness of
the ICHD 3 criteria, red and green flags. PLoS One. 2019. 14 (1):e0208728. [Medline]. [Full Text].

10. Hong CZ, Simons DG. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch Phys Med Rehabil.
1998 Jul. 79(7):863-72. [Medline].

11. Ballyns JJ, Shah JP, Hammond J, Gebreab T, Gerber LH, Sikdar S. Objective sonographic measures for characterizing myofascial
trigger points associated with cervical pain. J Ultrasound Med. 2011 Oct. 30(10):1331-40. [Medline].

https://emedicine.medscape.com/article/305937-print 15/16
4/11/2020 https://emedicine.medscape.com/article/305937-print
12. Ghanavatian S, Derian A. Tizanidine. 2018 Jan. [Medline]. [Full Text].

13. Park KD, Lee WY, Park MH, Ahn JK, Park Y. High- versus low-energy extracorporeal shock-wave therapy for myofascial pain
syndrome of upper trapezius: a prospective randomized single blinded pilot study. Medicine (Baltimore). 2018 Jul. 97 (28):e11432.
[Medline]. [Full Text].

14. Sherman KJ, Cherkin DC, Hawkes RJ, Miglioretti DL, Deyo RA. Randomized trial of therapeutic massage for chronic neck pain. Clin
J Pain. 2009 Mar-Apr. 25(3):233-8. [Medline].

15. Ma C, Szeto GP, Yan T, Wu S, Lin C, Li L. Comparing biofeedback with active exercise and passive treatment for the management
of work-related neck and shoulder pain: a randomized controlled trial. Arch Phys Med Rehabil. 2011 Jun. 92(6):849-58. [Medline].

16. Bronfort G, Evans R, Anderson AV, Svendsen KH, Bracha Y, Grimm RH. Spinal manipulation, medication, or home exercise with
advice for acute and subacute neck pain: a randomized trial. Ann Intern Med. 2012 Jan 3. 156(1 Pt 1):1-10. [Medline].

17. Ay S, Konak HE, Evcik D, Kibar S. The effectiveness of kinesio taping on pain and disability in cervical myofascial pain syndrome.
Rev Bras Reumatol. 2016 Mar 9. [Medline].

18. Moustafa IM, Diab AA, Hegazy F, Harrison DE. Does improvement towards a normal cervical sagittal configuration aid in the
management of cervical myofascial pain syndrome: a 1- year randomized controlled trial. BMC Musculoskelet Disord. 2018 Nov 12.
19 (1):396. [Medline]. [Full Text].

19. Aydin T, Dernek B, Senturk Ege T, Karan A, Aksoy C. The Effectiveness of Dry Needling and Exercise Therapy in Patients with
Dizziness Caused By Cervical Myofascial Pain Syndrome; Prospective Randomized Clinical Study. Pain Med. 2019 Jan 1. 20
(1):153-60. [Medline]. [Full Text].

20. Affaitati G, Costantini R, Tana C,et al. Effects of topical vs injection treatment of cervical myofascial trigger points on headache
symptoms in migraine patients: a retrospective analysis. J Headache Pain. 2018 Nov 8. 19 (1):104. [Medline]. [Full Text].

21. Nicol AL, Wu II, Ferrante FM. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched
protocol design. Anesth Analg. 2014 Jun. 118(6):1326-35. [Medline]. [Full Text].

https://emedicine.medscape.com/article/305937-print 16/16